What Causes Hypertrophic Cardiomyopathy?

被引:28
作者
Maron, Bradley A. [1 ]
Wang, Rui-Sheng [2 ]
Carnethon, Mercedes R. [3 ]
Rowin, Ethan J. [4 ]
Loscalzo, Joseph [1 ]
Maron, Barry J. [4 ]
Maron, Martin S. [4 ]
机构
[1] Harvard Med Sch, Dept Med, Div Cardiovasc Med, Boston 02115, MA USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA
[3] Feinberg Sch Med, Div Pulmonol & Crit Care, Chicago, IL USA
[4] Lahey Hosp & Med Ctr, HCM Ctr, Burlington, MA USA
关键词
CARDIAC-HYPERTROPHY; METABOLIC ABNORMALITIES; MYOCARDIAL FIBROSIS; MAGNETIC-RESONANCE; SYSTEMIC-SCLEROSIS; CLINICAL-COURSE; DISEASE; ASSOCIATION; SPECTROSCOPY; TACROLIMUS;
D O I
10.1016/j.amjcard.2022.06.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertrophic cardiomyopathy (HCM) is a global and relatively common cause of patient morbidity and mortality and is among the first reported monogenic cardiac diseases. For 30 years, the basic etiology of HCM has been attributed largely to variants in individual genes encoding cardiac sarcomere proteins, with the implication that HCM is fundamen-tally a genetic disease. However, data from clinical and network medicine analyses, as well as contemporary genetic studies show that single gene variants do not fully explain the broad and diverse HCM clinical spectrum. These transformative advances place a new focus on possible novel interactions between acquired disease determinants and genetic context to produce complex HCM phenotypes, also offering a measure of caution against overemphasizing monogenics as the principal cause of this disease. These new perspectives in which HCM is not a uniformly genetic disease but likely explained by multifactorial eti-ology will also unavoidably impact how HCM is viewed by patients and families in the clin-ical practicing community going forward, including relevance to genetic counseling and access to healthcare insurance and psychosocial wellness. Published by Elsevier Inc.
引用
收藏
页码:74 / 82
页数:9
相关论文
共 86 条
  • [1] Alfares AA, 2015, GENET MED, V17, P880, DOI [10.1038/gim.2014.205, 10.1038/gim.2015.16]
  • [2] Hypertrophic cardiomyopathy in systemic lupus erythematosus
    Anastasiadis, GP
    Moyssakis, I
    Boki, K
    Kyriakidis, M
    [J]. MAYO CLINIC PROCEEDINGS, 2001, 76 (01) : 111 - 111
  • [3] ASHERSON RA, 1992, J RHEUMATOL, V19, P1973
  • [4] HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH TACROLIMUS IN PEDIATRIC TRANSPLANT PATIENTS
    ATKISON, P
    JOUBERT, G
    BARRON, A
    GRANT, D
    PARADIS, K
    SEIDMAN, E
    WALL, W
    ROSENBERG, H
    HOWARD, J
    WILLIAMS, S
    STILLER, C
    [J]. LANCET, 1995, 345 (8954): : 894 - 896
  • [5] Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish
    Becker, Jason R.
    Deo, Rahul C.
    Werdich, Andreas A.
    Panakova, Daniela
    Coy, Shannon
    MacRae, Calum A.
    [J]. DISEASE MODELS & MECHANISMS, 2011, 4 (03) : 400 - 410
  • [6] Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
    Chan, Raymond H.
    Maron, Barry J.
    Olivotto, Iacopo
    Pencina, Michael J.
    Assenza, Gabriele Egidy
    Haas, Tammy
    Lesser, John R.
    Gruner, Christiane
    Crean, Andrew M.
    Rakowski, Harry
    Udelson, James E.
    Rowin, Ethan
    Lombardi, Massimo
    Cecchi, Franco
    Tomberli, Benedetta
    Spirito, Paolo
    Formisano, Francesco
    Biagini, Elena
    Rapezzi, Claudio
    De Cecco, Carlo Nicola
    Autore, Camillo
    Cook, E. Francis
    Hong, Susie N.
    Gibson, C. Michael
    Manning, Warren J.
    Appelbaum, Evan
    Maron, Martin S.
    [J]. CIRCULATION, 2014, 130 (06) : 484 - 495
  • [7] Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity
    Chatterjee, Shambhabi
    de Gonzalo-Calvo, David
    Derda, Anselm A.
    Schimmel, Katharina
    Sonnenschein, Kristina
    Bavendiek, Udo
    Bauersachs, Johann
    Baer, Christian
    Thum, Thomas
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [8] Programmable C:G to G:C genome editing with CRISPR-Cas9-directed base excision repair proteins
    Chen, Liwei
    Park, Jung Eun
    Paa, Peter
    Rajakumar, Priscilla D.
    Prekop, Hong-Ting
    Chew, Yi Ting
    Manivannan, Swathi N.
    Chew, Wei Leong
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [9] Comprehensive characterization of protein-protein interactions perturbed by disease mutations
    Cheng, Feixiong
    Zhao, Junfei
    Wang, Yang
    Lu, Weiqiang
    Liu, Zehui
    Zhou, Yadi
    Martin, William R.
    Wang, Ruisheng
    Huang, Jin
    Hao, Tong
    Yue, Hong
    Ma, Jing
    Hou, Yuan
    Castrillon, Jessica A.
    Fang, Jiansong
    Lathia, Justin D.
    Keri, Ruth A.
    Lightstone, Felice C.
    Antman, Elliott Marshall
    Rabadan, Raul
    Hill, David E.
    Eng, Charis
    Vidal, Marc
    Loscalzo, Joseph
    [J]. NATURE GENETICS, 2021, 53 (03) : 342 - +
  • [10] Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy
    Cole, Laura K.
    Mejia, Edgard M.
    Sparagna, Genevieve C.
    Vandel, Marilyne
    Xiang, Bo
    Han, Xianlin
    Dedousis, Nikolaos
    Kaufman, Brett A.
    Dolinsky, Vernon W.
    Hatch, Grant M.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 144 : 24 - 34